XML 87 R72.htm IDEA: XBRL DOCUMENT v3.8.0.1
Capital Stock (Stock Option, Restricted Stock and Restricted Share Unit Activity) (Details)
6 Months Ended
Sep. 30, 2017
$ / shares
shares
Class A Voting Shares | Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2017 (in shares) | shares 9,089,915
Granted (in shares) | shares 346,336
Options exercised (in shares) | shares (78,263)
Forfeited or expired (in shares) | shares (6,732)
Outstanding at September 30, 2017 (in shares) | shares 9,351,256
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2017, weighted average exercise price (in usd per share) | $ / shares $ 26.67
Granted, weighted average exercise price (in usd per share) | $ / shares 29.45
Options exercised, weighted average exercise price (in usd per share) | $ / shares 17.44
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 31.00
Outstanding at September 30, 2017, weighted average exercise price (in usd per share) | $ / shares $ 26.84
Class A Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2017 (in shares) | shares 519,148
Granted (in shares) | shares 64,946
Restricted stock or RSUs vested (in shares) | shares (219,493)
Forfeited or expired (in shares) | shares (5,335)
Outstanding at September 30, 2017 (in shares) | shares 359,266
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2017, weighted average grant-date fair value (in usd per share) | $ / shares $ 27.85
Granted, weighted average grant date fair value (in usd per share) | $ / shares 27.36
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 27.72
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 33.43
Outstanding at September 30, 2017, weighted average grant-date fair value (in usd per share) | $ / shares $ 27.77
Class B Non-Voting Shares | Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2017 (in shares) | shares 24,301,704
Granted (in shares) | shares 874,691
Options exercised (in shares) | shares (1,308,356)
Forfeited or expired (in shares) | shares (147,456)
Outstanding at September 30, 2017 (in shares) | shares 23,720,583
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2017, weighted average exercise price (in usd per share) | $ / shares $ 19.63
Granted, weighted average exercise price (in usd per share) | $ / shares 26.82
Options exercised, weighted average exercise price (in usd per share) | $ / shares 16.11
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 24.82
Outstanding at September 30, 2017, weighted average exercise price (in usd per share) | $ / shares $ 20.06
Class B Non-Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2017 (in shares) | shares 2,258,006
Granted (in shares) | shares 297,428
Restricted stock or RSUs vested (in shares) | shares (473,324)
Forfeited or expired (in shares) | shares (88,708)
Outstanding at September 30, 2017 (in shares) | shares 1,993,402
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2017, weighted average grant-date fair value (in usd per share) | $ / shares $ 26.07
Granted, weighted average grant date fair value (in usd per share) | $ / shares 26.91
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 26.63
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 26.19
Outstanding at September 30, 2017, weighted average grant-date fair value (in usd per share) | $ / shares $ 26.06